The security risks of mHealth apps

Mobile device health apps are helping transform healthcare, but their exploding use is also giving rise to new concerns about privacy and security. » Discussion

ADVERTISEMENT

Now FDA-Approved With a New Indication for Your Members
OLYSIO^® (simeprevir) 150-mg capsule
For more information,visit http://www.olysio.com/hcp/
^© Janssen Therapeutics, Division of Janssen Products, LP 2015 2/15 028680-150128

New HHS plan on opioids ups naloxone use

Health and Human Services recently launched a widespread initiative – including increasing the use of naloxone to reverse opioid overdoses – aimed at reducing prescription opioid- and heroin-related overdose, death and dependence. » Details

IN CASE YOU MISSED IT

• Cadillac tax causing firms to shed expensive policies

• Half of taxpayers would have to repay portion of ACA tax credit subsidies

• Hepatitis C therapies, compounded meds drive increase in U.S. drug spending

Keep in touch with MHE

We value your input. Please send your comments and article ideas to lisa.smith@advanstar.com.